Drugs / Influenza ModRNA Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06436703 | May 2024 → Feb 2025 | influenza | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza ModRNA Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06436703 ↗ |
| Modality | Messenger RNA (mRNA) | “modified RNA (modRNA) vaccines” NCT06436703 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT06436703 ↗ |